Search details
1.
Predictive factors for decompensating events in patients with cirrhosis with primary biliary cholangitis under different lines of therapy.
Hepatology
; 2024 Mar 06.
Article
in English
| MEDLINE | ID: mdl-38447019
2.
Budesonide as first-line treatment in patients with autoimmune hepatitis seems inferior to standard predniso(lo)ne administration.
Hepatology
; 77(4): 1095-1105, 2023 04 01.
Article
in English
| MEDLINE | ID: mdl-36626622
3.
Rituximab is a safe and effective alternative treatment for patients with autoimmune hepatitis: Results from the ColHai registry.
Liver Int
; 2024 May 29.
Article
in English
| MEDLINE | ID: mdl-38809086
4.
Outcomes and factors associated with relapse of vaccine-induced liver injury after SARS CoV-2 immunization: A nationwide study.
Ann Hepatol
; 29(3): 101489, 2024.
Article
in English
| MEDLINE | ID: mdl-38403068
5.
Obeticholic Acid and Fibrates in Primary Biliary Cholangitis: Comparative Effects in a Multicentric Observational Study.
Am J Gastroenterol
; 116(11): 2250-2257, 2021 11 01.
Article
in English
| MEDLINE | ID: mdl-34158466
6.
Post-colonoscopy colorectal cancer: Characteristics and predictive factors. / Cáncer colorrectal poscolonoscopia: características y factores predictivos.
Med Clin (Barc)
; 150(1): 1-7, 2018 Jan 12.
Article
in English, Spanish
| MEDLINE | ID: mdl-28606560
7.
Everolimus is safe within the first month after liver transplantation.
Transpl Immunol
; 33(2): 146-51, 2015 Oct.
Article
in English
| MEDLINE | ID: mdl-26392195
8.
Cáncer colorrectal poscolonoscopia: características y factores predictivos / Post-colonoscopy colorectal cancer: Characteristics and predictive factors
Med. clín (Ed. impr.)
; 150(1): 1-7, ene. 2018. tab, graf
Article
in Spanish
| IBECS (Spain) | ID: ibc-169652
Results
1 -
8
de 8
1
Next >
>>